Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment
Marie Lange, Natacha Heutte, Olivier Rigal, et al.
The Oncologist (2016) Vol. 21, Iss. 11, pp. 1337-1348
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors
Marie Lange, Florence Joly, Janette Vardy, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1925-1940
Open Access | Times Cited: 484
Cognitive Effects of Cancer and Cancer Treatments
Tim A. Ahles, James C. Root
Annual Review of Clinical Psychology (2018) Vol. 14, Iss. 1, pp. 425-451
Open Access | Times Cited: 274
Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis
Alexandra L. Whittaker, Rebecca P. George, Lucy O’Malley
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 105
Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study
Jeanne S. Mandelblatt, Brent J. Small, George Luta, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 32, pp. 3211-3222
Open Access | Times Cited: 153
Cognitive complaints in cancer survivors and expectations for support: Results from a web–based survey
Marie Lange, Idlir Licaj, Bénédicte Clarisse, et al.
Cancer Medicine (2019) Vol. 8, Iss. 5, pp. 2654-2663
Open Access | Times Cited: 112
Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients
Kerstin Hermelink, Markus Bühner, Philipp Sckopke, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 109, Iss. 10
Open Access | Times Cited: 104
Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions
Benjamin Ongnok, Nipon Chattipakorn, Siriporn C. Chattipakorn
Experimental Neurology (2019) Vol. 324, pp. 113118-113118
Closed Access | Times Cited: 102
Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 102
Taxane‐induced neurotoxicity: Pathophysiology and therapeutic perspectives
Robson da Costa, Giselle F. Passos, Nara Lins Meira Quintão, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 14, pp. 3127-3146
Open Access | Times Cited: 96
New Challenges in Psycho‐Oncology Research IV: Cognition and cancer: Conceptual and methodological issues and future directions
Tim A. Ahles, Arti Hurria
Psycho-Oncology (2017) Vol. 27, Iss. 1, pp. 3-9
Open Access | Times Cited: 88
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer
Achim Wöckel, Jasmin Festl, Tanja Stüber, et al.
Geburtshilfe und Frauenheilkunde (2018) Vol. 78, Iss. 11, pp. 1056-1088
Open Access | Times Cited: 78
Doxorubicin chemotherapy-induced “chemo-brain”: Meta-analysis
Sarah Eide, Zhong‐Ping Feng
European Journal of Pharmacology (2020) Vol. 881, pp. 173078-173078
Closed Access | Times Cited: 66
How to Identify and Manage Cognitive Dysfunction After Breast Cancer Treatment
Marie Lange, Florence Joly
Journal of Oncology Practice (2017) Vol. 13, Iss. 12, pp. 784-790
Closed Access | Times Cited: 62
Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy
Noemí Cerulla, J. Blas Navarro, Núria de la Osa
Journal of Cancer Survivorship (2020) Vol. 14, Iss. 4, pp. 464-482
Closed Access | Times Cited: 54
Chemotherapy and cognition: International cognition and cancer task force recommendations for harmonising preclinical research
Gordon Winocur, Ian Johnston, Hélène Castel
Cancer Treatment Reviews (2018) Vol. 69, pp. 72-83
Closed Access | Times Cited: 47
Animal models of chemotherapy-induced cognitive decline in preclinical drug development
Jeena John, Manas Kinra, Jayesh Mudgal, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3025-3053
Open Access | Times Cited: 37
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23
Nanotechnology Approaches for Prevention and Treatment of Chemotherapy‐Induced Neurotoxicity, Neuropathy, and Cardiomyopathy in Breast and Ovarian Cancer Survivors
Sarah Nevins, Callan D. McLoughlin, Alfredo Oliveros, et al.
Small (2023)
Open Access | Times Cited: 15
Effects of Chemotherapy on Attention Function in Breast Cancer Patients: Meta-analysis of Longitudinal Prospective Cohort Studies
Sun Ok Jung, A. Cho, Dong Won Yang, et al.
European Journal of Oncology Nursing (2025) Vol. 75, pp. 102820-102820
Closed Access
Systematic review of longitudinal studies on chemotherapy‐associated subjective cognitive impairment in cancer patients
Hee‐Ju Kim, Sun Ok Jung, Hyang Kim, et al.
Psycho-Oncology (2020) Vol. 29, Iss. 4, pp. 617-631
Closed Access | Times Cited: 38
Prevalence and associated factors of chemotherapy‐related cognitive impairment in older breast cancer survivors
Xuan Zhou, Xueyan Zhang, Tangsheng Zhong, et al.
Journal of Advanced Nursing (2023) Vol. 80, Iss. 2, pp. 484-499
Closed Access | Times Cited: 12
The regulation mechanism of perceived stress on cognitive function of patients with breast cancer undergoing chemotherapy: a multiple mediation analysis
Xiaotong Ding, Qing Wang, Houming Kan, et al.
Breast Cancer Research and Treatment (2025)
Closed Access
Advances in risk prediction models for cancer-related cognitive impairment
Ran Duan, ZuJun Wen, Ting Zhang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level
Joy Perrier, Armelle Viard, Christelle Lévy, et al.
Brain Imaging and Behavior (2018) Vol. 14, Iss. 1, pp. 226-241
Closed Access | Times Cited: 34
Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer
Marie Lange, Natacha Heutte, Sabine Noal, et al.
The Oncologist (2018) Vol. 24, Iss. 1, pp. 62-68
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top